Potential Early Warning System for Lung Cancer Identified

	Tweet

An immune system protein could act as an early warning system for lung cancer, reveals research published ahead of print in the journal Thorax.

Lung cancer kills around 900,000 people every year, and can take 20 years or more to develop fully. But it is usually only picked up at an advanced stage, when the chances of successful treatment are slim. 

As yet, there is no effective early warning system to detect the disease in its early treatable stages, and the dismal long term prospects of patients with lung cancer have changed little in the past 30 years.

The research team analysed blood (plasma) samples from 50 healthy volunteers and 104 people with different types of lung cancer.

They tested for autoantibodies - immune system proteins directed at the body’s own tissues in response to specific chemical signals in the body.

They looked in particular for a panel of seven autoantibodies, which are associated with ‘solid tumours,’ such a lung, breast, ovarian, and prostate cancers, and triggered when cancerous changes are taking place.

They found the presence of all seven autoantibodies, and very high levels of at least one of the seven in almost eight out of 10 samples taken from patients with confirmed lung cancer.

And these autoantibodies were found in eight out of the nine patients whose cancer had not infiltrated the lymph nodes, the body’s gatekeepers.

This indicates that the disease had not yet spread elsewhere and offers an 80% chance of a cure.

Only one healthy volunteer had more than one of these autoantibodies in their blood.

Other research has indicated that these autoantibodies can be picked up as early as five years before clinical symptoms start to show.

In a previous study, the researchers found abnormally high levels of specific autoantibodies in patients with breast cancer, prompting them to suggest that a test for these could be added to the screening programme. That study also showed that these autoantibodies were present before clinical symptoms appeared..

The authors argue that the lungs are especially sensitive to radiation, so repeated chest x-rays are not ideal for picking up lung cancer.

A blood test, on the other hand, is cheap compared with imaging techniques, and has no side effects. And the panel can be changed to include more or different autoantibodies for lung and other cancers.

They suggest that the blood test could be used for people at increased risk of developing the disease, such as smokers and passive smokers.

If they test positive, these people could then be referred for more detailed scans, such as computed tomography (CT) or magnetic resonance imaging (MRI), they suggest.

Source: British Medical Journal

RELATED STORIES:
Reduced lung function tied to lung cancer risk   Gold nanotech breath test may show lung cancer early   BATTLE Trial Personalizes Lung Cancer Therapy   New clinical trial for patients with asbestos-associated lung cancer   Quitting Smoking After Lung Cancer Diagnosis Can Prolong Life   WHO starts drive against environmental cancer risk   Advances in lung cancer research announced at conference   Early Diagnosis of Lung Cancer: Where Do We Stand?   Gene combination increases risk of lung cancer, particularly in light smokers, CAMH study finds   New hope for ways to overcome drug resistance in lung cancer   Non-Smokers with lung cancer respond better to treatment than smokers   CT screening can identify curable lung cancers   Gene Expression Profiling Advance for Lung Cancer Prognosis   Lung cancer slowed by Pfizer drug   Secondhand smoke exposure in childhood increases lung cancer risk later in life   Joining forces to improve lung cancer treatment   TRUST study data confirms safety and efficacy of erlotinib for advanced lung cancer   Lung cancer pill on NHS in 2007   Lung cancer patients with diabetes show prolonged survival   Risk of Surgery for Lung Cancer Lower at Teaching Hospitals   Marijuana tied to precancerous lung changes   African-Americans’ Attitudes About Lung Cancer May Hinder Prevention

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]